LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)
CUSIP: 528872302
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 427,442,892
- Total 13F shares
- 191,326,157
- Share change
- +45,718,730
- Total reported value
- $438,152,499
- Put/Call ratio
- 1002%
- Price per share
- $2.29
- Number of holders
- 121
- Value change
- +$104,558,326
- Number of buys
- 79
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 528872302?
CUSIP 528872302 identifies LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 528872302:
Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artal Group S.A. |
13F
|
Company |
21%
|
89,778,234
|
$218,161,000 | — | 31 Mar 2023 | |
| BVF INC/IL |
13F
|
Company |
3.8%
|
16,149,179
|
$39,242,505 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
5,656,927
|
$13,746,332 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
5,299,380
|
$12,877,493 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.2%
|
5,240,247
|
$12,733,800 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.77%
|
3,305,991
|
$8,034,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.69%
|
2,940,997
|
$7,146,623 | — | 31 Mar 2023 | |
| Invus US Partners LLC |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
5,782,749
|
$6,090,969 | — | 05 Aug 2022 | |
| NEA Management Company, LLC |
13F
|
Company |
0.56%
|
2,382,286
|
$5,788,955 | — | 31 Mar 2023 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.45%
|
1,940,224
|
$4,714,744 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
1,725,409
|
$4,192,743 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.37%
|
1,564,098
|
$3,798,703 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
763,264
|
$1,854,732 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
719,182
|
$1,747,056 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
688,611
|
$1,673,325 | — | 31 Mar 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.16%
|
675,328
|
$1,641,047 | — | 31 Mar 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.15%
|
649,726
|
$1,578,834 | — | 31 Mar 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.12%
|
516,367
|
$1,254,771 | — | 31 Mar 2023 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.09%
|
390,161
|
$949,000 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
0.08%
|
356,400
|
$866,052 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
317,502
|
$771,530 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
288,938
|
$702,120 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
263,875
|
$641,000 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.05%
|
208,333
|
$506,249 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
201,514
|
$489,000 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
198,304
|
$481,879 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
162,900
|
$395,847 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
159,000
|
$386,370 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.04%
|
156,621
|
$381,000 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.04%
|
151,493
|
$368,128 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
138,726
|
$337,104 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.03%
|
137,735
|
$334,697 | — | 31 Mar 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.03%
|
128,311
|
$311,795 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
125,066
|
$304,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
110,829
|
$269,315 | — | 31 Mar 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
101,158
|
$245,814 | — | 31 Mar 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
97,279
|
$236,388 | — | 31 Mar 2023 | |
| Lombard Odier SCmA Compagnie |
13F
|
Individual |
0.02%
|
94,000
|
$228,420 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
93,411
|
$226,989 | — | 31 Mar 2023 | |
| NATIXIS ADVISORS, LLC |
13F
|
Company |
0.02%
|
87,505
|
$213,000 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
69,791
|
$170,000 | — | 31 Mar 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
63,765
|
$154,949 | — | 31 Mar 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
63,385
|
$154,026 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
60,761
|
$147,649 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
60,723
|
$147,557 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.01%
|
55,327
|
$134,444 | — | 31 Mar 2023 | |
| CANADA LIFE ASSURANCE Co |
13F
|
Company |
0.01%
|
54,172
|
$131,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
53,293
|
$129,502 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
52,625
|
$127,878 | — | 31 Mar 2023 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.01%
|
46,489
|
$112,968 | — | 31 Mar 2023 |
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q2 2023
As of 30 Jun 2023,
LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
191,326,157 shares.
The largest 10 holders included
Artal Group S.A., BVF INC/IL, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, and Octagon Capital Advisors LP.
This page lists
121
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
102
Q2 2023 holders
121
Holder diff
19
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.